BOSTON SCIENTIFIC CORP — Director's Dealing 2021

Jul 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-07-23

Reporting Person: Eddy Jodi Euerle (SVP, Chief Info & Digital Off.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-23	Common Stock	M	8348.0000	$16.3100	Acquired	29853.0000	Direct
2021-07-23	Common Stock	M	3000.0000	$13.0800	Acquired	32853.0000	Direct
2021-07-23	Common Stock	S	11348.0000	$44.0000	Disposed	21505.0000	Direct
2021-07-27	Common Stock	S	728.0000	$45.0000	Disposed	20777.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-23	Stock Option (Right to Buy)	$16.3100	M	8348.0000	Disposed	2025-02-23	Common Stock (8348.0000)	Direct
2021-07-23	Stock Option (Right to Buy)	$13.0800	M	3000.0000	Disposed	2024-02-24	Common Stock (3000.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.